The University of Arizona
Map Home
Loading...
Adjust height of sidebar
KMap

Grant

A Phase 1/2, Safety Lead-in and Dose Expansion, Open-label, Multicenter Trial Investigating the Safety,Tolerability, and Preliminary Activity of Ivosidenib in Combination with Nivolumab and Ipilimumab

Active
$20.6K Funding
1 People
External

Related Topics

People